Available data support the oncologic safety of more conservative surgical approaches in breast cancer patients even with the highest penetrant germline variants like BRCA1 and BRCA2. Unaffected carriers may also be offered active surveillance should they choose so. The gene discussed is BRCA2; the disease is breast carcinoma.